Prosecution Insights
Prosecution Insights
Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Era Ophthalmica S R L is currently active in the Semiconductors, Circuits & Optics technology area with 1 pending office action. This matter is being examined by 1 distinct examiner within 1 distinct art unit. This suggests a specific technological focus, likely related to optical components or semiconductor applications. The presence of 1 pending office action indicates a streamlined prosecution profile that requires focused technical attention.
The busiest examiner for the company is PINKNEY, DAWAYNE, who is handling 1 pending office action. Since the company is working with 1 distinct examiner, the prosecution strategy can be tailored to the specific feedback and examination style of the individual. The use of 1 distinct art unit confirms that the technology is being reviewed within the Semiconductors, Circuits & Optics sector. This concentration allows for a direct and efficient dialogue with the patent office.
For a patent practitioner, the 1 pending office action requires a focused technical response. The concentration of the prosecution under the busiest examiner with 1 pending case simplifies the management of the portfolio. With the current workload, the company's immediate goal is to navigate the specific requirements of PINKNEY, DAWAYNE to move the application toward allowance. Successfully resolving the 1 pending case is the key priority.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PINKNEY, DAWAYNE | 1 | 80.7% | +17.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028954 | DEVICE FOR RETINAL NEUROMODULATION THERAPY AND EXTRAFOVEAL READING IN SUBJECTS AFFECTED BY VISUAL IMPAIRMENT | PINKNEY, DAWAYNE | 85d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028954 | DEVICE FOR RETINAL NEUROMODULATION THERAPY AND EXTRAFOVEAL READING IN SUBJECTS AFFECTED BY VISUAL IMPAIRMENT | PINKNEY, DAWAYNE | 85d overdue |
| Art Unit | Apps |
|---|---|
| 2872 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18028954 | DEVICE FOR RETINAL NEUROMODULATION THERAPY AND EXTRAFOVEAL READING IN SUBJECTS AFFECTED BY VISUAL IMPAIRMENT | PINKNEY, DAWAYNE | 2872 | §103§112 | Non-Final OA | 85d overdue | Pending | Mar 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial